MAP2K7 and neoplasm: While mTOR inhibition had limited effects in vitro, rapamycin potently inhibited tumor growth in vivo and subsequent drug withdrawal after 21 days of treatment was followed by a more durable response in a significant subset of tumor bearing mice with resulting prolonged survival compared to MEK inhibition.